- Filed
- Aug 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Jun 27, 2025 | 150.9M sh |
| Shares Diluted | Q1 2026 · Jun 28, 2024 | 149.23M sh |
| Capex | Q1 2026 · Jun 27, 2025 | $11.26M |
| Capex | Q1 2026 · Jun 28, 2024 | $2.89M |
| Operating Cash Flow | Q1 2026 · Jun 27, 2025 | $81.32M |
| Operating Cash Flow | Q1 2026 · Jun 28, 2024 | $120.85M |
| Cash And Equivalents | Q1 2026 · Jun 27, 2025 | $743.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $766.1M |
| Stockholders Equity | Q1 2026 · Jun 27, 2025 | $1.81B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.63B |
| Current Liabilities | Q1 2026 · Jun 27, 2025 | $1.03B |
| Current Liabilities | Q1 2026 · Mar 31, 2025 | $1.03B |
| Total Liabilities | Q1 2026 · Jun 27, 2025 | $1.58B |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $1.56B |
| Current Assets | Q1 2026 · Jun 27, 2025 | $2.23B |
| Current Assets | Q1 2026 · Mar 31, 2025 | $2.16B |
| Total Assets | Q1 2026 · Jun 27, 2025 | $3.39B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $3.19B |
| Eps Diluted | Q1 2026 · Jun 27, 2025 | $1.04 |
| Eps Diluted | Q1 2026 · Jun 28, 2024 | $0.84 |
| Eps Basic | Q1 2026 · Jun 27, 2025 | $1.06 |
| Eps Basic | Q1 2026 · Jun 28, 2024 | $0.86 |
| Sga Expense | Q1 2026 · Jun 27, 2025 | $73.94M |
| Sga Expense | Q1 2026 · Jun 28, 2024 | $60.83M |
| Rd Expense | Q1 2026 · Jun 27, 2025 | $21.56M |
| Rd Expense | Q1 2026 · Jun 28, 2024 | $16.52M |
| Net Income | Q1 2026 · Jun 27, 2025 | $157.18M |
| Net Income | Q1 2026 · Jun 28, 2024 | $121.7M |
| Operating Income | Q1 2026 · Jun 27, 2025 | $186.23M |
| Operating Income | Q1 2026 · Jun 28, 2024 | $160.09M |
| Gross Profit | Q1 2026 · Jun 27, 2025 | $281.73M |
| Gross Profit | Q1 2026 · Jun 28, 2024 | $237.44M |
| Cost Of Revenue | Q1 2026 · Jun 27, 2025 | $582.53M |
| Cost Of Revenue | Q1 2026 · Jun 28, 2024 | $482.48M |
| Revenue | Q1 2026 · Jun 27, 2025 | $864.25M |
| Revenue | Q1 2026 · Jun 28, 2024 | $719.92M |